Today: 8 June 2026
Micron Stock Rally: AI Memory Shortage Sends Market Value Past $850 Billion
9 May 2026
2 mins read

Micron Stock Rally: AI Memory Shortage Sends Market Value Past $850 Billion

NEW YORK, May 9, 2026, 09:15 (EDT)

Micron Technology Inc. (MU.O) popped more than 15% Friday, last changing hands at $746.81, pushing its market cap close to $853 billion as traders piled into memory-chip stocks linked to the AI data-center boom. Sandisk spiked over 16% as well. Reuters noted both Micron and Sandisk benefited from surging demand tied to the AI data center buildout.

This shift is significant right now; the AI trade has outgrown its early focus on graphics processors. Micron’s portfolio includes DRAM—essential for server and device memory—plus NAND flash storage, and HBM, or high-bandwidth memory. That last one gets stacked close to AI processors to speed up data transfers.

That puts Micron in a select group alongside South Korea’s SK Hynix and Samsung Electronics. On May 8, Reuters reported SK Hynix was fielding an unusual rush of investment proposals from major global tech companies, with buyers eager to lock in memory chip supply. SK Hynix, Samsung, and Micron have each confirmed ongoing discussions with customers about multi-year supply deals.

Micron delivered numbers that pushed the rally forward. Fiscal Q2 revenue surged, nearly tripling year-on-year to $23.86 billion. GAAP net income landed at $13.79 billion, or $12.07 per share. “Memory has become a strategic asset for our customers,” CEO Sanjay Mehrotra said. For the fiscal third quarter, the company is targeting revenue of $33.5 billion, give or take $750 million. Micron Technology

Micron is putting more money into the crunch. The company, in its prepared remarks, said it sees DRAM and NAND supply-demand staying tight past calendar 2026. For fiscal 2026, capital expenditures—covering plant and equipment investments—are projected to top $25 billion.

Wall Street’s in step. Mizuho’s Vijay Rakesh bumped his Micron price target up to $740 from $545 and stuck with his Outperform call. According to Investing.com, Rakesh pointed to “agentic AI is driving memory demand higher” as the reason. That’s AI capable of managing tasks with less intervention from humans, not just following step-by-step prompts. Investing.com

Some are cutting to the chase on the shortage. “Memory chips are the AI bottleneck,” Roundhill CEO Dave Mazza told Business Insider. He pointed out that bringing new fabrication plants online is a three-to-five-year process, and noted that Micron’s HBM supply for 2026 is already locked up under fixed pricing deals. Business Insider

The rally comes with strings attached. Bernstein analyst Mark Li is forecasting a sharp jump in memory contract prices for the second quarter, but the firm points to some conflicting signs in the spot market: price hikes are already cooling consumer demand, and both original equipment makers and module houses have been pulling back on purchases. Bernstein doesn’t see the price momentum lasting—expecting a significant slowdown in increases by the third quarter.

Signs of strain are emerging across end markets. Sony is now projecting a 6% decline in annual gaming sales, down to 4.42 trillion yen. The company points to surging memory chip prices as a key headwind for the industry and warns its PlayStation 5 hardware forecast hinges on securing enough memory at what it calls “reasonable prices.” Reuters

For Micron, it comes down to whether those multi-year customer deals will actually smooth out the sharp swings that have long defined memory markets. The way shares are moving, investors clearly think supply stays tight for now. The catch: prices could climb quickly enough to scare off buyers before fresh capacity is online.

Stock Market Today

  • Jim Cramer's Charitable Trust Trims Goldman Sachs and Qnity Electronics Amid Market Uncertainty
    June 8, 2026, 9:59 AM EDT. Jim Cramer's Charitable Trust is selling 20 shares of Goldman Sachs at about $1,051 each, reducing its portfolio weighting from 4.5% to 4%, and trimming 70 shares of Qnity Electronics at roughly $146, lowering its stake from 3.12% to 2.9%. These moves aim to raise cash following last Friday's market selloff triggered by concerns over large upcoming IPOs and potential stock offerings from tech giants like Meta Platforms, Microsoft, and Amazon. The trust has realized gains of approximately 84% on Goldman Sachs and 61% on Qnity Electronics since their purchase. Despite the short-term repositioning, the trust remains optimistic about long-term opportunities in AI development.

Latest articles

Corning Wins Amazon AI Fiber Deal; GLW Faces Next Hurdle

Corning Wins Amazon AI Fiber Deal; GLW Faces Next Hurdle

8 June 2026
Amazon’s new multibillion-dollar supply deal makes Corning a key fiber provider for U.S. data centers, but with shares up 305% in 12 months and investors already pricing in big AI wins, the stock was little changed at $177.58 premarket as risks of factory delays and high expectations loom.
BlackBerry Shares Stall After QNX Push

BlackBerry Stock Moves in Pre-Market Ahead of June Test

8 June 2026
BlackBerry’s U.S. shares rose 2.34% in premarket trading to $9.63 after Friday’s 8.99% drop, but with analyst targets averaging just $4.98, investors are betting on QNX growth and secure-communications wins ahead of June 25 earnings; any disappointment could hit the stock hard.
Micron Technology Stock Surges as AI Memory Shortage Puts MU at Center of Chip Rally

Micron Shares Edge Up in Premarket; Investors Await Next AI Test

8 June 2026
Micron surged 8.2% to $935.07 in Nasdaq premarket after Friday’s $127 billion rout, as investors cheered Nvidia’s confirmation it will keep sourcing high-bandwidth memory from Micron and Samsung, easing fears SK Hynix would become exclusive supplier; Cantor Fitzgerald raised its price target to $1,500, with Micron’s next earnings report due June 24.
Tango Therapeutics Stock Surges After Cancer Drug Shows 92% Response Rate

Tango Therapeutics Stock Surges After Cancer Drug Shows 92% Response Rate

8 June 2026
Tango shares soared up to 48% in premarket trading after reporting a 92% objective response rate and 90% six-month progression-free survival in a 12-patient pancreatic cancer trial, with plans to advance the vopimetostat-daraxonrasib combo to Phase 3 testing in first-line MTAP-deleted pancreatic cancer.
Dell Stock Surges 13% After Trump Praise — Why AI Servers Are the Bigger Story
Previous Story

Dell Stock Surges 13% After Trump Praise — Why AI Servers Are the Bigger Story

Intel Stock Jumps on Apple Chip Deal: Why the Foundry Bet Suddenly Matters
Next Story

Intel Stock Jumps on Apple Chip Deal: Why the Foundry Bet Suddenly Matters

Go toTop